At KitoZyme, we verified the feasibility of KitoGreen project to optimize our disruptive biostimulants manufacturing platform and release it into market. While we are carrying out an on-going Proof of Concept study, long term safety and efficacy of our current generation of KitoGreen products, a group of fungal-derived chitosan formulations acting as biostimulants for specific crops, we plan to: optimize these formulations, and improve our manufacturing capability and technology transfer. Thus, we assessed all the investment required to complete the project, for which we will pursue financing support of €1.71M from the EC scheme of Accelerator project. We have also evaluated the potential of KitoGreen to generate >€2.88M profit and new employment. Moreover, we have already received proofs of interest from our key stakeholders: consultancy companies, and manufacturers and distributors in the field of agronomy. Furthermore, we have already established a partnership to secure our European distribution channels with one the major agriculture input distributor.
Consequently, we finally decided to continue with KitoGreen project, motivated by the confirmation of the uniqueness and competitiveness of our innovation with this feasibility study.